Search

Your search keyword '"Oromendia, Clara"' showing total 229 results

Search Constraints

Start Over You searched for: Author "Oromendia, Clara" Remove constraint Author: "Oromendia, Clara"
229 results on '"Oromendia, Clara"'

Search Results

1. Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument.

2. Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort.

Catalog

Books, media, physical & digital resources

3. Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS.

4. Paired Associative Stimulation as a Tool to Assess Plasticity Enhancers in Chronic Stroke.

8. Clinical features of neuroendocrine prostate cancer

22. Supplementary Data from A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers

24. Serum proteomic profiling of rheumatoid arthritis–interstitial lung disease with a comparison to idiopathic pulmonary fibrosis

25. The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy

26. A Comparative Analysis of the Respiratory Subscore of the Sequential Organ Failure Assessment Scoring System

27. Evaluation of Technology-Enabled Monitoring of Patient-Reported Outcomes to Detect and Treat Toxic Effects Linked to Immune Checkpoint Inhibitors

28. Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation

29. Serum proteomic profiling of rheumatoid arthritis-interstitial lung disease with a comparison to idiopathic pulmonary fibrosis.

30. Attributable mortality of acute respiratory distress syndrome: a systematic review, meta-analysis and survival analysis using targeted minimum loss-based estimation

32. Technology-enabled longitudinal monitoring of patient-reported outcomes (PROs) to individualize care of immune-related adverse events (irAEs) in patients (pts) treated with immune checkpoint inhibitors (ICIs).

34. Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort

35. Persistent severe acute respiratory distress syndrome for the prognostic enrichment of trials

36. Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis

37. Rapidly Improving ARDS in Therapeutic Randomized Controlled Trials

39. Validation of risk factors for recurrence of renal cell carcinoma: Results from a large single-institution series

41. Paired Associative Stimulation as a Tool to Assess Plasticity Enhancers in Chronic Stroke

42. Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis

44. Clinical improvement with intensive robot-assisted arm training in chronic stroke is unchanged by supplementary tDCS

47. The genomic landscape of metastatic clear cell renal cell carcinoma (ccRCC) after treatment with systemic therapy.

48. Clinical and molecular analysis of patients treated with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy.

49. Acute respiratory distress syndrome without identifiable risk factors: A secondary analysis of the ARDS network trials